AI assistant
Sending…
ROCKET PHARMACEUTICALS, INC. — Director's Dealing 2023
Apr 13, 2023
33148_dirs_2023-04-12_cf8c71a6-4428-40d6-9172-5ee462b87bb7.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: ROCKET PHARMACEUTICALS, INC. (RCKT)
CIK: 0001281895
Period of Report: 2023-04-04
Reporting Person: White Mark Andrew (N/A)
More from ROCKET PHARMACEUTICALS, INC.
Regulatory Filings
2026
May 21
Regulatory Filings
2026
Apr 28
Proxy Solicitation & Information Statement
2026
Apr 6
Major Shareholding Notification
2026
Mar 27
Regulatory Filings
2026
Mar 27
Regulatory Filings
2026
Mar 2
Regulatory Filings
2026
Feb 26
Annual Report
2026
Feb 26
Director's Dealing
2026
Feb 20
Director's Dealing
2026
Feb 20